Deciphera Pharmaceuticals, Inc. financial data

Industry
Pharmaceutical Preparations
Location
200 Smith Street, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Deciphera Pharmaceuticals, LLC (to 8/15/2017)
Latest financial report
10-Q - Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 434 % -19.9%
Quick Ratio 29.3 % +8.86%
Debt-to-equity 30.9 % +13.3%
Return On Equity -52.4 % -12.6%
Return On Assets -40 % -9.43%
Operating Margin -118 % +13.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 86.5M shares +10.1%
Common Stock, Shares, Outstanding 82.2M shares +4.65%
Entity Public Float 777M USD +22.2%
Common Stock, Value, Issued 821K USD +4.59%
Weighted Average Number of Shares Outstanding, Basic 87.4M shares +5.7%
Weighted Average Number of Shares Outstanding, Diluted 87.4M shares +5.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 175M USD +26.5%
Research and Development Expense 237M USD +21.5%
Costs and Expenses 381M USD +16.5%
Operating Income (Loss) -207M USD -9.23%
Nonoperating Income (Expense) 16.6M USD +103%
Net Income (Loss) Attributable to Parent -190M USD -4.8%
Earnings Per Share, Basic -2.21 USD/shares -1.84%
Earnings Per Share, Diluted -2.21 USD/shares -1.84%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.2M USD -20.4%
Marketable Securities, Current 223M USD -14.3%
Accounts Receivable, after Allowance for Credit Loss, Current 32.7M USD +45.7%
Inventory, Net 26M USD +1.97%
Other Assets, Current 1.39M USD
Assets, Current 350M USD -26.5%
Property, Plant and Equipment, Net 5.16M USD -20.8%
Operating Lease, Right-of-Use Asset 30.9M USD -12.8%
Assets 421M USD -23.3%
Accounts Payable, Current 19.5M USD -1.07%
Employee-related Liabilities, Current 7.92M USD -27.4%
Liabilities, Current 83.4M USD -0.58%
Operating Lease, Liability, Noncurrent 21.4M USD -14.3%
Liabilities 105M USD -3.72%
Accumulated Other Comprehensive Income (Loss), Net of Tax 98K USD
Retained Earnings (Accumulated Deficit) -1.47B USD -14.8%
Stockholders' Equity Attributable to Parent 316M USD -28.2%
Liabilities and Equity 421M USD -23.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -54.6M USD -10.4%
Net Cash Provided by (Used in) Financing Activities 522K USD -99.6%
Net Cash Provided by (Used in) Investing Activities 62.6M USD
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 82.2M shares +4.65%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91.2M USD -20.4%
Deferred Tax Assets, Valuation Allowance 377M USD +15.2%
Deferred Tax Assets, Gross 377M USD +15.2%
Operating Lease, Liability 25.9M USD -11.1%
Payments to Acquire Property, Plant, and Equipment 146K USD -59.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -190M USD -4.89%
Lessee, Operating Lease, Liability, to be Paid 30.6M USD -13.5%
Property, Plant and Equipment, Gross 17.6M USD +4.93%
Operating Lease, Liability, Current 3.57M USD +8.27%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.94M USD +1.69%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.85M USD +1.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.75M USD -24.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.02M USD +1.68%
Deferred Tax Assets, Operating Loss Carryforwards 211M USD -1.37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.14M USD +69.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.1M USD +1.63%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 450K USD -26%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 48.3M USD -3.84%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%